-
Biopharmaceutical Formulation Stability Solutions
17 Oct 2025 16:54 GMT
… Stability Assessment
Comprehensive characterization of biopharmaceutical formulation stability requires orthogonal analytical … , and manufacturing process optimization. As biopharmaceuticals continue dominating pharmaceutical development pipelines …
-
<![CDATA[Roundup: Biopharmaceutical Industry Activity Accelerates with Focus on Rare Diseases and Novel Therapies]]>
15 Oct 2025 17:07 GMT
The biopharmaceutical industry landscape is undergoing a …
-
International Biopharma Industry Week Shanghai 2025 Kicks Off -- Building a Global Magnet for Full-Chain Biopharmaceutical Innovation
15 Oct 2025 16:21 GMT
… platform for full-chain biopharmaceutical innovation, supporting Shanghai in … State-owned Capital Investment Biopharmaceutical Industry Ecosystem Cooperation Fund. … and investors from the global biopharmaceutical community; representatives from national …
-
Protein Crystallization Market Poised for Breakthrough Growth Amid Rising Biopharmaceutical Innovations 2025-2032
15 Oct 2025 12:34 GMT
… novel therapeutics, vaccines, and biopharmaceuticals. Advances in crystallography techniques … high-throughput applications.
Biopharmaceutical companies are increasingly investing … by increasing investments in biopharmaceutical research, advancements in …
-
Barrier Packaging Solutions for Biopharmaceuticals
13 Oct 2025 19:58 GMT
… Barrier Solutions for Different Biopharmaceutical Formats
Injectable biopharmaceuticals require packaging solutions that … growing trend toward personalized biopharmaceutical treatments.
Conclusion: Advancing Biopharmaceutical Protection Excellence
Advanced …
-
Soleno Therapeutics Appoints Biopharmaceutical Executive Mark W. Hahn to its Board of Directors
13 Oct 2025 12:00 GMT
… , Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for … , today announced the appointment of biopharmaceutical finance veteran Mark W. Hahn …
-
Interest Rates Tumble: Grab Our 5 All-Time Favorite Safe 6%+ Dividend Stocks
18 Oct 2025 04:31 GMT
… , manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It pays a …
-
5% Yielding Dividend Blue-Chip Giants in Demand as Yields Fall
18 Oct 2025 04:31 GMT
… Myers Squibb is a global biopharmaceutical company committed to discovering, developing …
-
A pharma loser and 3 growers: Inside Sunil Singhania’s big small-cap bet
18 Oct 2025 01:01 GMT
… Ltd is a clinical-stage biopharmaceutical company focused on the acquisition …
-
Summit Therapeutics Announces Expansion of Ivonescimab Global Phase III Development Program with HARMONi-GI3 Study in 1L Colorectal Cancer
17 Oct 2025 22:14 GMT
… Summit Therapeutics Inc. is a biopharmaceutical oncology company focused on the …